Johnson & Johnson on Wednesday forecast 12.5% growth in its annual adjusted profit after completing the separation of consumer health company Kenvue.
The company expects 2023 adjusted reported earnings per share of $10.00 - $10.10 in 2023, reflecting increased growth of 12.5% at the mid-point.
(Reporting by Manas Mishra in Bengaluru)
